Help us improve resources for patients with rheumatic conditions! This is a brief, anonymous survey aimed to gather information about what additional resources you'd like to learn about from your rheumatology care team. Learning about your interest and priorities will inform future development of programs, resources, and tools to promote health.

Would you like to learn more about your body composition and resting metabolic rate? If you identify as Asian and are between 18-35 years old, you may be eligible to participate in a research study evaluating body composition and metabolic health in multiple Asian ethnicities.

Do you have a cough that hasn't gone away for more than 8 weeks? Does your cough bother you or make it hard to do normal activities? If your cough continues and you feel it is not well managed, you may be able to participate in a research study to find out how chronic cough is treated and how it affects daily life and other health conditions. Compensation provided.

Do you have plaque type psoriasis? You may be able to participate in a research study to find out if an investigational medication (zasocitinib) works better than an already FDA approved medication for psoriasis (deucravacitinib).

Are you battling triple-negative breast cancer? If your cancer has come back or spread, and you haven't started treatment yet, you might qualify for a clinical trial testing a new medication. Discover more about this opportunity to find a potentially better treatment option.

Do you have acid reflux, GERD, or Barrett's Esophagus? Are you having standard of care endoscopies performed? You may be able to participate in a research study testing for Barrett's Esophagus and esophageal cancer. Compensation provided.

Have you diagnosed with lymph node positive early breast cancer, have received surgery, and have not received any systemic or radiation treatment prior to surgery? If so, you may be able to take part in this clinical trial which seeks to improve the treatment of early-stage breast cancer by examining ctDNA, a biomarker found in the blood that may indicate the presence of disease. This study aims to determine if ctDNA can help doctors personalize therapies leading to more effective treatment plans.

Have you been diagnosed with Leukemia? Do you have a functioning kidney, liver, and cardiac organ? If so, you may be able to participate in a study on a new drug called LBS-007. We want to find out if it is safe for people with Leukemia. Compensation provided.

Are you currently using insulin to treat type 2 diabetes? Are your blood sugar values still not where your provider wants them to be? If you are willing to use an automated insulin delivery system, involving an insulin pump and a continuous glucose monitor, you may be eligible to participate in a research study to find out if the twiist system can improve glycemic control.

Have you been diganosed with epithelial high grade ovarian, fallopian tube or primary peritoneal carcinoma? if so, you may be able to participate in this research study to evaluate if the combination of Trastuzumab Deruxtecan (T-DXd) and Bevacizumab works better than bevacizumab alone for the treatment of your type of cancer.